TOMI Environmental Solutions Inc.'s (TOMZ:OTCQB) products kill pathogens—safely and effectively. Not just the coronavirus: Ebola, MERS, C. diff spores, sepsis, norovirus, anthrax, Staphylococcus, MRSA, Legionnaire's and Zika. The kill list also includes food borne illnes...
Streetwise Reports
|
February 19, 2020
|
As it has done with cobalt , graphite and rare earths , China appears to be locking up the nickel market. Nickel’s top producer, Indonesia, in early September decided to accelerate a scheduled ban on ore export shipments, from 2022 to January 1, 2020. The...
Richard (Rick) Mills
|
November 6, 2019
|
Cybin X Kernel "A New Frontier in Psychedelic Therapeutics" About the partnership: Cybin Corporation ( N.CYBN , Forum ) will leverage Kernel’s Flow to quantify brain activity during psychedelic experiences in re...
Featured Submission
|
January 11, 2021
|
Author: Gus Richler, The Deep Dive. The activity and press releases coming out of Washington over cryptocurrencies points to a new normal. Cryptocurrencies are a real thing, what with the creation of both the Strategic Bitcoin Reserve and the US Digital Asset Stockp...
Research
|
March 19, 2025
|
About a month ago, market participants around the world learned that the end of a price slide does not have to end at zero on the expiry date of WTI contracts. Anyone who thought that a barrel of American WTI at USD 0.01, which is 159 litres of crude oil, would be a special ba...
Mario Hose
|
May 19, 2020
|
In the past, people have accepted that it usually takes about ten years to get a vaccine on the market. Careful testing with proof of success is required for a preparation to receive approvals. Since COVID-19, the pressure to develop has increased dramatically and also the pot...
Mario Hose
|
September 1, 2020
|
When the Corona Pandemic started in November 2019 in Wuhan, China, nobody could have guessed the extent of the disease. Socially, economically and politically, Covid-19 has turned the world upside down. With increasing knowledge in dealing with the Corona Virus, people around ...
Mario Hose
|
September 23, 2020
|
Deciphera Pharmaceuticals announced positive top-line results from the INVICTUS pivotal phase 3 clinical study of ripretinib in patients with advanced gastrointestinal stromal tumors. Early this morning, clinical-stage biopharmaceutical company Deciphera Pharmaceutic...
Streetwise Reports
|
August 14, 2019
|
It’s the Holy Grail in the cannabis industry. Everyone is trying to innovate the best delivery system to optimize the “bioavailability” (uptake) of medical cannabis in order to offer the perfect pairing -- precise dosing with a fast on...
Marc Davis
|
January 8, 2020
|
It has the potential to be one of the most disruptive pharmaceutical drug therapies of the modern era, especially for treating Alzheimer’s disease. And that gives it considerable “blockbuster drug” potential – a tantalising opportunity tha...
Marc Davis
|
June 25, 2021
|